Electrolytic liver ablation is not associated with evidence of a systemic inflammatory response syndrome

British Journal of Surgery

Volumn 91, Issue 2, 2004, Pages 178-183

  Teague, B D ^a   Court, F G ^a   Morrison, C P ^a   Kho, M ^a   Wemyss Holden, S A ^a   Maddern, G J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATININE; INTERLEUKIN 1BETA; LIVER ENZYME; TUMOR NECROSIS FACTOR ALPHA; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DATA ANALYSIS; DISEASE ASSOCIATION; ELECTROLYSIS; ELECTROSURGERY; ENZYME BLOOD LEVEL; EVIDENCE BASED MEDICINE; KIDNEY FUNCTION; LIVER FUNCTION; LIVER SURGERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE COUNT; UREA BLOOD LEVEL;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; C-REACTIVE PROTEIN; CATHETER ABLATION; ELECTROLYSIS; FEMALE; INTERLEUKIN-1; LIVER; LIVER NEOPLASMS; PLATELET COUNT; RISK FACTORS; SERUM; SWINE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1242320277     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4400     Document Type: Article

References (14)

1. Teague BD, Wemyss-Holden SA, Fosh BG, Dennison AR, Maddern GJ. Electrolysis and other local ablative treatments for non-resectable colorectal liver metastases. Aust N Z J Surg 2002; 72: 137-141.
2. Sato M, Watanabe Y, Kashu Y, Nakata T, Hamada Y, Kawachi K. Sequential percutaneous microwave coagulation therapy for liver tumor. Am J Surg 1998; 175: 322-324.
3. Shimada S, Hirota M, Beppu T, Matsuda T, Hayashi N, Tashima S et al. Complications and management of microwave coagulation therapy for primary and metastatic liver tumors. Surg Today 1998; 28: 1130-1137.
4. Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg 1999; 23: 109-114.
5. Seifert J, Finlay J, Armstrong N, Morris D. Thrombocytopenia and cytokine release following hepatic cryosurgery. Aust N Z J Surg 1998; 68: 526 (Abstract).
6. Seifert JK, Stewart GJ, Hewitt PM, Bolton EJ, Junginger T, Morris DL. Interleukin-6 and tumour necrosis factor-alpha levels following hepatic cryotherapy: association with volume and duration of freezing. World J Surg 1999; 23: 1019-1026.
7. Wemyss-Holden SA, Robertson GS, Hall PDL, Dennison AR, Maddern GJ. Electrolytic treatment of colorectal tumour deposits in a rat model: a technique with potential for patients with unresectable liver tumours. Dig Dis 2000; 18: 50-57.
8. Wemyss-Holden SA, Dennison AR, Finch GJ, Hall PDL, Maddern GJ. Electrolytic ablation as an adjunct to liver resection: experimental studies of predictability and safety. Br J Surg 2002; 89: 579-585.
9. Xin YL. Organisation and spread of electrochemical therapy in China. Eur J Surg Suppl 1994; 574: 25-29.
10. Fosh BG, Finch JG, Lea M, Black C, Wong S, Wemyss-Holden S et al. Use of electrolysis as an adjunct to liver resection. Br J Surg 2002; 89: 999-1002.
11. Court FG, Wemyss-Holden SA, Morrison CP, Teague BD, Laws PE, Kew J et al. Segmental nature of the porcine liver and its potential as a model for experimental partial hepatectomy. Br J Surg 2003; 90: 440-444.
12. Chapman WC, Debelak JP, Wright Pinson C, Washington MK, Atkinson JB, Venkatakrishnan A et al. Hepatic cryoablation, but not radiofrequency ablation, results in lung inflammation. Ann Surg-2000; 231: 752-761.
13. Blackwell TS, Debelak JP, Venkatakrishnan A, Schot DJ, Harley DH, Pinson CW et al. Acute lung injury after hepatic cryoablation: correlation with NF-kappa B activation and cytokine production. Surgery 1999; 126: 518-526.
14. Blackwell TS, Christman JW. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol 1997; 17: 3-9.